[Typhoid and paratyphoid fever].

Z Gastroenterol

Bereich Infektions- und Tropenmedizin, Klinik und Poliklinik für Gastroenterologie, Hepatologie, Infektiologie, Pneumologie, Universitätsklinikum Leipzig.

Published: February 2020

AI Article Synopsis

  • Typhoid and paratyphoid fevers are serious global diseases caused by Salmonella Typhi and Salmonella Paratyphi, primarily transmitted through contaminated food and water, and often resulting in high fever; untreated typhoid can be life-threatening.
  • The infections predominantly occur outside Europe, especially in India, and in some countries like Germany, Austria, and Switzerland, they must be reported.
  • Current treatments face challenges due to increasing antibiotic resistance, highlighting the urgent need for more effective vaccines that provide better protection against both types of Salmonella.

Article Abstract

Typhoid fever and paratyphoid fever are systemic infectious diseases of global significance caused by Salmonella enterica subspecies enterica Serovar Typhi (short name: Salmonella Typhi) or Serovar Paratyphi (short name: Salmonella Paratyphi). The course of these fecal-orally transmitted diseases is mainly characterized by a high fever. Left untreated, the course of typhoid fever can be severe and lethal. The infection is almost always acquired outside of Europe (mainly in India) and is notifiable in Germany, Austria and Switzerland. Paratyphoid is an attenuated disease of typhoid fever caused by Salmonella Paratyphi. Available vaccines only protect against Salmonella Typhi. Antibiotic resistance reflects the situation in endemic countries and shows a worrying increase of multi-drug resistant isolates. Currently, third-generation cephalosporins such as ceftriaxone are recommended as first-line therapy; if sensitive to quinolones, fluoroquinolones such as ciprofloxacin may continue to be administered. Crucial preventive measures for travelers to endemic regions include consistent water and food hygiene as well as vaccination, whereby only protection rates of 50-70 % are achieved by currently available vaccines. In the light of increasing multi-drug resistance, a more effective conjugate vaccine against Salmonella Typhi with cross-reactivity against Salmonella Paratyphi is needed more than ever.

Download full-text PDF

Source
http://dx.doi.org/10.1055/a-1063-1945DOI Listing

Publication Analysis

Top Keywords

typhoid fever
12
salmonella typhi
12
salmonella paratyphi
12
caused salmonella
8
short salmonella
8
salmonella
7
fever
5
[typhoid paratyphoid
4
paratyphoid fever]
4
fever] typhoid
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!